Market Cap : 13.85 B | Enterprise Value : 13.79 B | PE Ratio : | PB Ratio : 119.14 |
---|
NAS:NVAX has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:NVAX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Novavax's other long-term liabilities for the quarter that ended in Sep. 2020 was $211.1 Mil.
Novavax's quarterly other long-term liabilities increased from Mar. 2020 ($9.6 Mil) to Jun. 2020 ($210.5 Mil) and increased from Jun. 2020 ($210.5 Mil) to Sep. 2020 ($211.1 Mil).
Novavax's annual other long-term liabilities declined from Dec. 2017 ($10.3 Mil) to Dec. 2018 ($8.7 Mil) but then increased from Dec. 2018 ($8.7 Mil) to Dec. 2019 ($10.1 Mil).
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.
No Headline